Archive | Melanoma News

Steep rise in skin cancer since 1960s

The risk of developing more than one skin melanoma over a ten-year period has seen a ten-fold increase in Sweden since the 1960s, a new study by researchers at Karolinska Institutet and Lund University published in the Journal of the National Cancer Institute reports.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Neoadjuvant Nivolumab/Ipilimumab Improves RFS in Stage III Macroscopic Melanoma

The neoadjuvant combination of nivolumab (Opdivo) and ipilimumab (Yervoy) continued to demonstrate a benefit in relapse-free survival (RFS) compared with the combination given in the adjuvant setting in patients with stage III macroscopic melanoma, according to 3-year follow-up results of the phase 1b OpACIN trial.1

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

The predictive and prognostic significance of cell-free DNA concentration in melanoma

In this study with a discovery cohort (n = 20) and expansion cohort (n = 166) including metastatic melanoma patients and healthy donors (n = 116), researchers sought to validate universal predictive and prognostic biomarkers, given that most of the liquid?biopsy biomarkers depend on the analyses of oncogenic mutations, however, approximately 20% of melanoma patients […]

Read the full story

Posted in Melanoma News, Publications, Scientific Publications

Real-world outcomes of advanced melanoma patients not represented in phase 3 trials

Researchers sought to report on systemically treated patients with advanced melanoma, that were not represented in phase 3 trials, to support clinical decision?making.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications